In recent years, the use of injectable weight-loss medications, particularly GLP-1 drugs like Wegovy and Zepbound, has become increasingly widespread. However, a pertinent question arises regarding the consequences of ceasing these treatments. While anecdotal evidence largely...
The introduction of popular weight-loss medications in India last year has not only prompted a significant surge in consumer demand but also led to a remarkable increase in public discourse surrounding obesity. From conversations led by...
Medications initially developed for managing diabetes and obesity are broadening their therapeutic applications. Recently, treatments based on the hormone GLP-1 have demonstrated benefits not...
Comedian and social media influencer Aishwarya Mohanraj has recently spoken candidly about her journey with weight loss, highlighting her experience with Mounjaro, a GLP-1...
The so-called “Devil Weight-Loss Plan” has recently drawn widespread attention after a young woman in China reportedly lost nearly 15 kg in just two...
Imagine improving your metabolism, burning more calories, and slowing down aging—without adding a single thing to your to-do list. No extra workouts. No strict...
Danish pharmaceutical giant Novo Nordisk has officially launched its much-awaited weight loss drug, Wegovy, in India. With obesity rates rising sharply across the country,...
